Who are COLD BLOOD BASED CARDIOPLEGIA's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Microplegic Solution No. 1, Del Nido.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cold-blood-based-cardioplegia.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

COLD BLOOD BASED CARDIOPLEGIA — Competitive Intelligence Brief

COLD BLOOD BASED CARDIOPLEGIA (COLD BLOOD BASED CARDIOPLEGIA) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cardioplegic solution. Area: Cardiovascular.

marketed Cardioplegic solution Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

COLD BLOOD BASED CARDIOPLEGIA (COLD BLOOD BASED CARDIOPLEGIA) — JESSICA GARCIA SUAREZ. Cold blood-based cardioplegia is a solution used during cardiac surgery to induce cardiac arrest and protect the heart from ischemic injury by rapidly cooling and chemically arresting myocardial function.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
COLD BLOOD BASED CARDIOPLEGIA TARGET	COLD BLOOD BASED CARDIOPLEGIA	JESSICA GARCIA SUAREZ	marketed	Cardioplegic solution
Microplegic Solution No. 1	Microplegic Solution No. 1	Washington University School of Medicine	marketed	Cardioplegic solution
Del Nido	Del Nido	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	marketed	Cardioplegic solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cardioplegic solution class)

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · 1 drug in this class
JESSICA GARCIA SUAREZ · 1 drug in this class
Washington University School of Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). COLD BLOOD BASED CARDIOPLEGIA — Competitive Intelligence Brief. https://druglandscape.com/ci/cold-blood-based-cardioplegia. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab